Survival for invasive mole and choriocarcinoma

Survival for invasive mole and choriocarcinoma is very high. Nearly all women are cured.

The statistics here are intended as a general guide and can't tell you what is likely to happen in your individual case.

Your doctor can give you more information about your own outlook (prognosis).

Survival by risk group

Chemotherapy works very well for most women with invasive mole or choriocarcinoma. Those who need chemotherapy are divided into 3 different risk groups - low risk, high risk and ultra high risk disease. 

There are no UK wide statistics for invasive mole and choriocarcinoma.

Results are available from research undertaken at the specialist UK centres that treat these conditions. In this research, women were followed up for between 1 and 16 years after their diagnosis. The number of people included is quite low, particularly for the ultra high risk group.

Low risk disease

All women (100%) with low risk disease are successfully treated.

High risk disease

All those (100%) with high risk disease are successfully treated.

Ultra high risk disease

Around three quarters (75%) of those with ultra high risk disease are successfully treated.